Slagelse

• A Phase 3 Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of MK-0616 in Reducing Major Adverse Cardiovascu … Not authorised
  2022-502781-24-00 11 ASCVD - Atherosclerotic Cardiovascular Disease
• Intraperitoneal treatment with fosfomycin, metronidazole and recombinant human granulocyte-macrophage colony-stimulating factor in patients … Not authorised
  2024-520317-49-00 3 peritonitis
• Intraperitoneal treatment with fosfomycin, metronidazole and recombinant human granulocyte-macrophage colony-stimulating factor in patients … Pending
  2024-520317-49-02 3 peritonitis
• RESET C2 Pending
  2026-525214-62-00 4 Localised dMMR Colon Cancer
• Empirical Meropenem versus Piperacillin/Tazobactam for Adult Patients with Sepsis (EMPRESS) Recruiting
  2023-509703-33-00 6 2025-06-26 Septic Shock
• The Intensive Care Platform Trial (INCEPT) Recruiting
  2024-516208-41-00 6 2025-06-26 Acute critical illness requiring intensive care unit admission.
• ZENITH: Zilebesiran in Patients with Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk … Recruiting
  2025-522960-34-00 5 2026-02-09 Established cardiovascular disease
• EASi-PROTKT™ - A study to test vicadrostat (BI 690517) taken together with empagliflozin in people with type 2 diabetes, high blood pressure … Recruiting
  2025-521188-11-00 5 2025-10-15 Type 2 diabetes
• A Trial to Test How AZD0780 Affects Serious Heart, Stroke, or Vascular Problems in Patients with Heart, Stroke or Vascular Disease or at Hig … Recruiting
  2025-520519-14-00 5 2025-09-03 Atherosclerotic Cardiovascular Disease
• A study to test whether vicadrostat (BI 690517) in combination with empagliflozin helps people with heart failure and a weak pumping functio … Recruiting
  2024-519525-38-00 5 2025-08-22 Heart failure
• Brachial plexus nerve block for closed reduction of distal radius fracture Recruiting
  2024-512191-35-00 6 2024-12-10 Distal radius fracture in need of acute closed reduction
• Tittle: Effects of intravenous administered iron in non-anemic iron deficient patients with colorectal cancer. A double blinded clinical ran … Recruiting
  2024-518517-26-00 4 2024-10-10 Iron deficiency
• DAPHNE Recruiting
  2024-510746-14-00 6 2024-08-28 Axial Spondyloarthritis
• New treatments to reduce cardiovascular disease in type 1 diabetes Recruiting
  2023-505794-32-04 5 2024-07-05 Type 1 diabetes
• Intratumoral Flu Vaccine and Pembrolizumab in Colorectal Cancer Recruiting
  2023-503228-17-00 4 2023-11-06 Colorectal Cancer
• VASODILATATION OR LOOP-DIURETICS FOR INITIAL TREATMENT OF PULMONARY CONGESTION DUE TO ACUTE HEART FAILURE – A RANDOMIZED PLACEBO-CONTROLLED … Recruiting
  2022-500035-36-01 6 2023-09-14 Acute heart failure with pulmonary congestion
• INVITED trial Recruiting
  2022-500906-17-01 4 2023-03-21 Type 1 diabetes
• A Phase 3 Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of MK-0616 in Reducing Major Adverse Cardiovascu … Ended recruitment
  2022-502781-24-01 5 2024-06-05 ASCVD - Atherosclerotic Cardiovascular Disease
• Early versus postponed supplementary parenteral nutrition after major emergency abdominal surgery Ended recruitment
  2023-505378-14-00 6 2023-10-18 Major emergency abdominal surgery
• LIBREXIA-AF A Phase 3 Active-controlled Study of Milvexian for Prevention of Cardioembolic Events in Participants with Atrial Fibrillation Ended recruitment
  2022-501419-15-00 5 2023-08-23 Atrial Fibrillation
• OCEAN(a)-Outcomes – Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction – Outcomes trial Ended recruitment
  2022-501608-85-00 5 2023-05-09 Cardiovascular disease (atherosclerotic cardiovascular disease (ASCVD)
• REDEFINE 3: A research study to see the effects of CagriSema in people living with diseases in the heart and blood vessels Ended recruitment
  2023-506924-94-00 5 2023-02-28 Cardiovascular disease
• Bicarbonate for the treatment of cardiac arrest Ended recruitment
  2022-501304-10-00 6 2023-02-06 In-hospital cardiac arrest
• Efficacy and safety of remibrutinib compared to teriflunomide in participants with relapsing multiple sclerosis, followed by long term treat … Ended recruitment
  2023-509345-12-00 5 2022-06-22 Multiple Sclerosis

Showing 1–24 of 29 trials